Factors such as the presence of a favorable business
environment, growing government support through funds and grants, growing
number of research activities, rising number of drug discovery initiatives by
pharmaceutical & biotechnology companies in the US, and the strong presence
of key players in this region are driving the growth of the cell analysis
market in North America.
The Cell Analysis
Market is expected to reach USD 22.7 billion by 2024
from USD 16.0 billion in 2019, at a CAGR of 7.2%. from 2019 to 2024 Increasing
government funding for cell-based research and the rising incidence of chronic
and infectious diseases are the major factors driving the growth of this
market.
Based on product, the cell analysis market is broadly
categorized into microscopes, flow cytometry products, spectrophotometers, qPCR
products, cell counters, cell microarrays, high-content screening (HCS)
systems, and other products. The flow cytometry products segment accounted for
the largest market share in 2018. The large share of this segment is primarily
attributed to technological advancements, the increasing adoption of flow
cytometry techniques in research and academia, growing public-private
initiatives in the field of immunology and immuno-oncology research, and the
rising incidence and prevalence of chronic diseases.
Based
on end user, the cell analysis market is segmented into hospitals & diagnostic
laboratories, research institutes, pharmaceutical & biotechnology companies
and CROs, cell culture collection repositories, and other end users. The
pharmaceutical & biotechnology companies and CROs segment is expected to
register the highest CAGR during the forecast period. These facilities use cell
analysis instruments and consumables during various stages of drug discovery,
drug research and development, pharmacokinetics, toxicology, and clinical
studies.
By region, the cell analysis market is segmented into North
America, Europe, the Asia Pacific, Latin America, and the Middle East &
Africa. In 2018, North America accounted for the largest market share, followed
by Europe.
The
prominent players operating in the cell analysis market are Danaher Corporation
(US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck
KGaA (Germany), GE Healthcare (US), Agilent Technologies, Inc. (US), Olympus
Corporation (Japan), PerkinElmer, Inc. (US), Promega Corporation (US), Tecan
Group (Switzerland), Miltenyi Biotec (Germany), Carl Zeiss (Germany), Bio-Rad
Laboratories Inc (US), and Sysmex Corporation (Japan).
No comments:
Post a Comment